drugset / Trial / NCT01490658
Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers
RandomizedCrossoverSingle-blindTreatment
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to compare repaglinide and metformin as co-administered tablets and as a combination tablet.
Timeline
- Start
- 2006-06
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | — |
| Subject | Repaglinide | Small molecule | 1 mg | — |
| Subject | Repaglinide | Small molecule | 2 mg | — |